Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The acquired resistance of tumor cells to TKIs is partially reversed by inhibiting IGFBP-1 and the combination of antiangiogenic TKIs and IGFBP-1 inhibitors may be a promising therapeutic strategy for HCC (135)
All products mentioned in this article are sold by Durham Peptides for research and laboratory use only
While NMN can be a great tool for long-term wellness, NAD+ therapy delivers direct and often faster benefits
State which basis is being used in the record
Avellar, Universidade Federal de Sao Paulo, Brazil
(RAR) S1 File
US$ 23.26
US$ 27.82
US$ 23.19
US$ 28.04
US$ 25.04
US$ 21.37
US$ 23.21
